Peptide appearance Lyophilized form

Muscle Growth

15 000+ verified orders

CJC-1295 with DAC

In stock

CJC-1295+DAC is one of modified synthetic analogues of growth hormone releasing hormone (GHRH). It acts as a growth hormone (GH) secretagogue stimulating levels of GH and insulin-like growth factor 1 (IGF-1), while preserving GH pulsatility. This stimulation in turn is the basis for its effects confirmed in various studies in animals and humans. This peptide contains an additive called DAC - Drug Affinity Complex, which is added to the CJC-1295 molecule via a lysine linker, and provides protection during circulation in the bloodstream. The DAC enhances the pharmacokinetics of the peptide, and allows it to bind to the blood protein albumin, thereby extending the half-life of CJC-1295 relative to other similar analogue molecules and natural GHRH itself..
Available strengths
88,90 €
Buy 2, get 1 free. €100 in paid peptide vials · water excluded
Bundle & save

Arrives 26 – 30 November to Europe

We accept Visa Mastercard Apple Pay (when supported) Google Pay (when supported) Klarna (where available) Shown at checkout

CJC-1295 with DAC

88,90 €

DAC-linked GHRH analogue for albumin-binding and extended-exposure pathway studies.

SKU: ADRIA-CJC-DAC Categories: , Tags: ,

Compound information

Specifications

Molecular profile

Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(N-epsilon-maleimidopropionyl)-NH2
Molecular mass
3647.2 g/mol
CAS number
446262-90-4
Molecular formula
C165H269N47O46

Material record

Physical appearance
White to off-white lyophilized powder
Solubility
Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
Product note
Albumin-binding GHRH analogue research compound; supplied strictly for research use only.

Research overview

CJC-1295 with DAC

Description of CJC-1295+DAC?

The CJC-1295+DAC peptide was made by ConjuChem Biotechnologies up of the first 29 amino acids of GHRH combined with a DAC supplement that allows to prolong the half-life and duration of action of the peptide CJC-1295. GHRH, the growth hormone releasing hormone, has been modified several times to create analogues that would have similar effects to GHRH, since its use is limited by short duration of action. This particular GHRH analogue was created in an attempt to find a more soluble GH secretagogue that could both be easily produced in large quantities and preserve or prolong the effects of GHRH action in the body. Although CJC-1295+DAC is chemically very similar to other GHRH analogues such as Sermorelin or even more to GRF (1-29), which is the most similar to it, they are not identical. Subcutaneous administration of CJC-1295 caused in healthy adults dose-dependent increase in GH and IGF-1 levels, which was well tolerated and safe.

[2]

Overview of Published Research

Studies have confirmed that after a single injection of CJC-1295 it increases growth hormone (GH) levels in mice and also in healthy human adults by about 2-10-times, with GH reaching peak levels approximately 2 hours after administration of the peptide and the effects lasting for six or more days thereafter. GHRH analogue increases also the IGF-1 concentration by 1,5-3-fold for 9-11 days, whereas the half-life was 5,8-8,1 d.

Maintaining the physiological effect on GH release is critical in affecting the maximum concentration of the hormone in the blood without adverse reaction or increased side effects. Unlike other GH secretagogues, CJC-1295 preserves normal physiological growth hormone release with unchanged frequency and magnitude of GH secretory pulses when the peptide is administered. However, basal levels of growth hormone can be increased. The CJC-1295+DAC peptide has been shown in research to preserve the physiological effects of GH on protein synthesis, myocardial function, bone density, hyperplasia, blood sugar, lipid metabolism or hypertrophy.

[1] [2]

Research has indicated that the peptide may be of potential interest in the context of normalizing growth issues. Although children with GH deficiency have a good response to GHRH administration, its therapeutical effects are limited because of very short half-life.

Research has indicated that the peptide may be of potential interest in the context of normalizing growth issues. Although children with GH deficiency have a good response to GHRH administration, its therapeutical effects are limited because of very short half-life.

[3]

Scientists have found some in vivo and in vitro evidence that ovarian follicular cycle and ovulation is influenced and stimulated by IGF-1 hormones, and probably also by the release of growth hormone. It is for this reason that the CJC-1295 peptide, as well as other GHRH analogues, could be of research interest in the context of inducing ovulation in infertile women. This is suggested by research done back in the early 1990s and confirmed by another that investigated superovulation in animals. Growth hormone and IGF-1 levels rose significantly just during ovulation and exogenous administration of growth hormone secretagogues, such as CJC-1295, induced ovulation. It has also been suggested that the peptide and other GHRH analogues could potentially act on sperm production in men and may be relevant to research into male infertility. Further research will, hopefully, clearly define the precise role of GH in the induction of ovulation, and the minimum dose of GH needed to sensitize the ovary, as well as influences on men infertility.

[4]

All presented information is based on scientific publications which can be found in

For laboratory purposes and personal observation only. Not for human consumption.

Laboratory care

Handling

Peptides in transport

Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.

Storage of lyophilized peptides

Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Up to 3 months
  • Refrigerated (2–8 °C): Up to 6 months
  • Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)

Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.

Storage of reconstituted peptides

Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.

The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Avoid prolonged storage
  • Refrigerated (2–8 °C): Typically 4–8 weeks
  • Frozen (-20 °C or below): Up to 3–4 months

To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.

Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.

Analytical documentation

Tests

Latest published result

Liquilabs s.r.o.Signed Certificate of Analysis · 5 mg

Certificate preview for 5 mg

98.6%Purity by HPLC

Batch number
6158307
Tested
2026-09-08

Recorded QC panel

AssayPeptide Screening 0.1% TFA
4.10 mg (± 0.02 mg)
PurityPeptide Screening 0.1% TFA
98.6%
Identity (FTIR)Peptide Screening 0.1% TFA
980 (± 5)
Identity (RT)Retention time
0.997 (± 0.005)
Bacterial endotoxinUSP 85 / Eur. Ph. 2.6.14
Less than 0.001 EU/mg

These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.

See all test results

Signed certificate

Source record

References

1.

M. Ionescu and L. A. Frohman, "Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog," J. Clin. Endocrinol. Metab., vol. 91, no. 12, pp. 4792–4797, Dec. 2006.

2.

Sam L. Teichman et al., „Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults, 91(3):799-805, Epub 2005 Dec 13.

3.

M. Alba et al., "Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse," Am. J. Physiol. Endocrinol. Metab., vol. 291, no. 6, pp. E1290-1294, Dec. 2006.

4.

A. Volpe, G. Coukos, A. Barreca, G. Giordano, P. G. Artini, and A. R. Genazzani, "Clinical use of growth hormone-releasing factor for induction of superovulation," Hum. Reprod., vol. 6, no. 9, pp. 1228–1232, Oct. 1991.

5.

National Center for Biotechnology Information

PubChem Compound Summary: CJC-1295

Authoritative identity record for CJC-1295 with DAC.

PubChem View source ↗
6.

Teichman SL, Neale A, Lawrence B, et al. · 2006

Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of growth hormone-releasing hormone, in healthy adults

Primary characterisation of CJC-1295 as a long-acting GHRH analogue.

Journal of Clinical Endocrinology and Metabolism · 10.1210/jc.2005-1536 View source ↗
7.

Sackmann-Sala L, Ding J, Frohman LA, et al. · 2009

Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

Primary CJC-1295 study reporting serum-protein profiling.

Growth Hormone and IGF Research · 10.1016/j.ghir.2009.03.001 View source ↗
8.

M. Ionescu and L. A. Frohman · 2006

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog

J. Clin. Endocrinol. Metab
9.

· 2005

Sam L. Teichman et al., „Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults, 91(3):799-805, Epub 2005 Dec 13

10.

M. Alba et al. · 2006

Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse

Am. J. Physiol. Endocrinol. Metab
11.

A. Volpe, G. Coukos, A. Barreca, G. Giordano, P. G. Artini, and A. R. Genazzani · 1991

Clinical use of growth hormone-releasing factor for induction of superovulation

Hum. Reprod

Customer reviews

4.7/5185+ reviews
View on Trustpilot ↗Checked 17 Nov 2026

Quality products,fast shipping,great refferal plan,only downside is that products in 4 mounths since my first order got more and more expensive ,but overall verry good experience.

Read full review →

More than 2 weeks for package dispatch. They promised one free peptide next time. Sent me new tracking number but package still wasn't delivered to fedex. Last package (much much cheaper) was delivered in less than week. I will update if they will send my package. ok,package sent.

Read full review →

Extremely satisfied with the product quality and overall experience. The customer service is polite and quick. All recommendations!

Read full review →

Trustworthy site with a huge catalog of products. Been purchasing from them for some time now never got disappointed. I could only recommend them.

Read full review →

Everything ok. With little problem with package, but after contact with Customer Service everything went right. Good quality of products

Read full review →

Excellent. Buying peptides online can be nerve wracking! But Adria are very transparent about all the checks and certifications. My experience with them was excellent. Great products at good prices and efficient P&P

Read full review →